KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $9.4 million.

  • Guardant Health's Depreciation & Amortization (CF) fell 1122.85% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year decrease of 621.71%. This contributed to the annual value of $42.4 million for FY2024, which is 115.2% down from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Depreciation & Amortization (CF) is $9.4 million, which was down 1122.85% from $10.0 million recorded in Q2 2025.
  • Guardant Health's 5-year Depreciation & Amortization (CF) high stood at $11.0 million for Q3 2023, and its period low was $5.0 million during Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $9.1 million, with a median of $10.2 million in 2022.
  • Per our database at Business Quant, Guardant Health's Depreciation & Amortization (CF) soared by 7689.39% in 2022 and then tumbled by 1122.85% in 2025.
  • Over the past 5 years, Guardant Health's Depreciation & Amortization (CF) (Quarter) stood at $6.1 million in 2021, then soared by 66.98% to $10.2 million in 2022, then rose by 6.87% to $10.9 million in 2023, then decreased by 3.81% to $10.5 million in 2024, then dropped by 10.01% to $9.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $9.4 million in Q3 2025, compared to $10.0 million in Q2 2025 and $10.2 million in Q1 2025.